Recombinant Anti-Human VEGF Antibody (Fc glycosylation)
CAT#: Gly-143LC
This product is a humanized monoclonal antibody with 74% G0F glycoform in the Fc region. The glycoengineered antibody with enhanced ADCC and CDC specifically binds human VEGF and can be potentially used in the treatment of vascular diseases.
Glyco-engineering
- Glycosylation site
- Asn297 in Fc region
- Glycoform (ratio)
- G0F (74%)
- Glycosylation Type
- N-glycosylation
- Activity
- Improve the CDC and ADCC functions
Specifications
- Target
- VEGF (Vascular endothelial growth factor)
- Host Species
- Human
- Derivation
- Humanized
- Type
- Humanized antibody
- Specificity
- Human
- Antibody Isotype
- IgG
- Expression Host
- Recombinant CHO cell line
- Applications
- ELISA
Target
- Alternative Names
- VEGF; Vascular endothelial growth factor
- Related Disease
- Vascular diseases
Customer Review
There are currently no Customer reviews or questions for Gly-143LC. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Related Diseases
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "VEGF"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MHH-1036-F(E) | Recombinant Human Anti-VEGF Antibody Fab Fragment | ELISA, IF, FuncS | Fab |
| HPAB-2709LY-F(E) | Human Anti-VEGF Recombinant Antibody (clone YS03); Fab Fragment | ELISA | Human Fab |
| HPAB-AP213-YC-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-AP213-YC-F(E)) | ELISA | Human Fab |
| HPAB-2806LY-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-2806LY-F(E)) | ELISA, WB | Humanized Fab |
| HPAB-2807LY-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-2807LY-F(E)) | ELISA, WB | Humanized Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-658CL | Human Anti-VEGF Recombinant Antibody (TAB-658CL) | ELISA | Human IgG |
| TAB-407CQ | Human Anti-VEGF Recombinant Antibody (TAB-407CQ) | ELISA | Humanized IgG |
| TAB-408CQ | Human Anti-VEGF Recombinant Antibody (TAB-408CQ) | ELISA | Humanized IgG |
| TAB-407CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-407CQ-S(P)) | ELISA | Humanized scFv |
| TAB-408CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-408CQ-S(P)) | ELISA | Humanized scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-0345CL-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment (4D3) | ELISA, FuncS, Inhib | |
| TAB-0346CL-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment (FD006) | ELISA, FuncS, Inhib | Human antibody |
| TAB-409CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-409CQ-S(P)) | ELISA | Human scFv |
| TAB-410CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-410CQ-S(P)) | ELISA | Human scFv |
| PABX-186 | Human Anti-VEGF Recombinant Antibody (PABX-186) | WB, ELISA, FuncS | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-288CQ | Human Anti-VEGF Recombinant Antibody (TAB-288CQ) | ELISA | Chimeric (Mouse/Human) IgG1, κ |
| TAB-301CQ | Human Anti-VEGF Recombinant Antibody (TAB-301CQ) | ELISA, FC, IHC, WB | Chimeric (Mouse/Human) IgG1, κ |
| TAB-288CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-288CQ-S(P)) | ELISA, WB, IHC, Block | Human scFv |
| PABX-185 | Recombinant Human Anti-VEGF Antibody (Fab-12) | ELISA, FuncS | IgG |
| PABX-185-F (E) | Recombinant Mouse Anti-VEGF Antibody Fab Fragment (Fab-12) | ELISA, FuncS | Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-285CQ-S(P) | Mouse Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-285CQ-S(P)) | ELISA, WB, Neut | Mouse scFv |
| TAB-287CQ-S(P) | Mouse Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-287CQ-S(P)) | ELISA, WB, IHC, Block | Mouse scFv |
| TAB-290CQ-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment | ELISA, WB, Neut | |
| TAB-303CQ-S(P) | Anti-Human VEGF Recombinant Antibody scFv Fragment (TAB-303CQ-S(P)) | ELISA, WB, Neut | |
| PABX-185-S (P) | Recombinant Mouse Anti-VEGF Antibody scFv Fragment (Fab-12) | ELISA, FuncS | scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-096LC | Recombinant Anti-Human VEGF Antibody (Fc glycosylation) | ELISA | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-179LC | Recombinant Anti-Human VEGF Antibody (Non-glycosylated) | ELISA | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-4485 | Rabbit Anti-VEGF Recombinant Antibody (clone SI581DS) | ELISA | Rabbit IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-2709LY-S(P) | Human Anti-VEGF Recombinant Antibody (clone YS03); scfv Fragment | ELISA | Human scfv |
| HPAB-2806LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2806LY-S(P)) | ELISA, WB | Humanized scfv |
| HPAB-2807LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2807LY-S(P)) | ELISA, WB | Humanized scfv |
| HPAB-2808LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2808LY-S(P)) | ELISA, WB | Humanized scfv |
| HPAB-2809LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2809LY-S(P)) | ELISA, WB | Humanized scfv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-2806LY | Human Anti-VEGF Recombinant Antibody (HPAB-2806LY) | WB, FuncS | Humanized IgG |
| HPAB-2807LY | Human Anti-VEGF Recombinant Antibody (HPAB-2807LY) | ELISA, WB | Humanized IgG |
| HPAB-2808LY | Human Anti-VEGF Recombinant Antibody (HPAB-2808LY) | ELISA, WB | Humanized IgG |
| HPAB-2809LY | Human Anti-VEGF Recombinant Antibody (HPAB-2809LY) | ELISA, WB | Humanized IgG |
| HPAB-2810LY | Human Anti-VEGF Recombinant Antibody (HPAB-2810LY) | ELISA, WB | Humanized IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-J0267-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0267-YC) | ELISA, Neut | Camelid VHH |
| HPAB-J0268-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0268-YC) | ELISA, Neut | Camelid VHH |
Popular Products

Application: ELISA, IP, FC, FuncS, Neut, IF, ICC

Application: ELISA, FC, IP, FuncS, IF, Neut, ICC

Application: WB, FC, IP, ELISA, Neut, FuncS, IF

Application: WB, ELISA, FuncS

Application: WB, ELISA, FuncS
-CB2006C17L-4.jpg)
Application: WB, ELISA

Application: ELISA, IHC, FC, IP, IF, FuncS

Application: WB, ELISA, FC, IHC, IF, IP

Application: ELISA, WB, FC, IHC, IP

Application: ELISA, FC, Inhib

Application: IF, ICC, WB, IHC-P, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Bladder Cancer
Rheumatoid Arthritis











